Odyssey
  • Homepage
  • Objectives
  • News
  • Publications
  • Contact
  • Restricted
Select Page

First patient enrolled in ODYSSEY study

by odysseyadmin | Sep 21, 2016 | ODYSSEY

First patient enrolled in ODYSSEY study We are happy to announce that the first patient was enrolled in the ODYSSEY study by the team in Zimbabwe. We encourage all the sites to follow. Back to...

Recent Posts

  • Dolutegravir for Children living with HIV
  • ODYSSEY trial plays an important role in the FDA approval of dolutegravir for children – a big step towards timely access to optimal ART for children.
  • What does COVID-19 mean for those living in HIV communities?
  • ODYSSEY trial: COVID-19 response and CROI update
  • Adeqaute dolutegravir exposure dosed BID with rifampicin in children 6 to < 18 years

Recent Comments

    Archives

    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • August 2019
    • July 2019
    • March 2019
    • July 2018
    • June 2018
    • April 2018
    • August 2017
    • September 2016

    Categories

    • ODYSSEY
    • Publication

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    This study is funded by ViiV Healthcare and the sponsor is PENTA Foundation